HKEx Stock Code: 01093English|繁體|简体

Highlight - 2019 Interim

Revenue
RMB11,178 mn, +27.6%
Profit attributable to shareholders
RMB1,878 mn, +24.8%
Basic earnings per share
RMB30.13 cents, +25.0%

Key Products

Innovative drugs
Common generic drugs
Bulk drugs
© Copyright 2019 CSPC Pharmaceutical Group Limited. All Rights Reserved.